| Ident. | Authors (with country if any) | Title |
|---|
| 000032 (2020) |
Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine] | [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking]. |
| 000046 (2020) |
E. Davenne [Belgique] ; J B Giot [Belgique] ; P. Huynen [Belgique] | [Coronavirus and COVID-19 : focus on a galopping pandemic]. |
| 000050 (2020) |
Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine] | [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019]. |
| 000067 (2020) |
Mary A. Lake [Royaume-Uni] | What we know so far: COVID-19 current clinical knowledge and research. |
| 000078 (2020) |
Yuefei Jin [République populaire de Chine] ; Haiyan Yang [République populaire de Chine] ; Wangquan Ji [République populaire de Chine] ; Weidong Wu [République populaire de Chine] ; Shuaiyin Chen [République populaire de Chine] ; Weiguo Zhang [République populaire de Chine] ; Guangcai Duan [République populaire de Chine] | Virology, Epidemiology, Pathogenesis, and Control of COVID-19. |
| 000095 (2020) |
Mingxiang Ye [République populaire de Chine] ; Dian Fu [République populaire de Chine] ; Yi Ren [République populaire de Chine] ; Faxiang Wang [République populaire de Chine] ; Dong Wang [République populaire de Chine] ; Fang Zhang [République populaire de Chine] ; Xinyi Xia [République populaire de Chine] ; Tangfeng Lv [République populaire de Chine] | Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. |
| 000098 (2020) |
Amy Heinzerling ; Matthew J. Stuckey ; Tara Scheuer ; Kerui Xu ; Kiran M. Perkins ; Heather Resseger ; Shelley Magill ; Jennifer R. Verani ; Seema Jain ; Meileen Acosta ; Erin Epson | Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient - Solano County, California, February 2020. |
| 000101 (2020) |
Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin Chen | Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective |
| 000123 (2020) |
Weilong Shang ; Yi Yang ; Yifan Rao ; Xiancai Rao | The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines |
| 000125 (2020) |
Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan Yan | The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status |
| 000138 (2020) |
Huilan Tu [République populaire de Chine] ; Sheng Tu [République populaire de Chine] ; Shiqi Gao [République populaire de Chine] ; Anwen Shao [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] | The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event |
| 000149 (2020) |
Y J Duan [République populaire de Chine] ; Q. Liu [République populaire de Chine] ; S Q Zhao [République populaire de Chine] ; F. Huang [République populaire de Chine] ; L. Ren [République populaire de Chine] ; L. Liu [République populaire de Chine] ; Y W Zhou [République populaire de Chine] | The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 （COVID-19） and Its Research Progress in Forensic Toxicology. |
| 000151 (2020) |
Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine] | The Science Underlying COVID-19: Implications for the Cardiovascular System. |
| 000152 (2020) |
Mengmeng Li [République populaire de Chine] ; Liang Chen [République populaire de Chine] ; Jingxiao Zhang [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] | The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. |
| 000186 (2020) |
Jiayu Liao [États-Unis] ; George Way [États-Unis] ; Vipul Madahar [États-Unis] | Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies. |
| 000216 (2020) |
Swapna Thampi [Singapour] ; Andrea Yap [Singapour] ; Fan Lijia [Singapour] ; Jacqueline Ong [Singapour] | Special considerations for the management of COVID-19 pediatric patients in the operating room and pediatric intensive care unit in a tertiary hospital in Singapore. |
| 000217 (2020) |
Lishan Huang ; Guanwen Lin ; Li Tang ; Lingna Yu ; Zhilai Zhou | Special attention to nurses’ protection during the COVID-19 epidemic |
| 000236 (2020) |
Nisreen M A. Okba ; Marcel A. Müller ; Wentao Li ; Chunyan Wang ; Corine H. Geurtsvankessel ; Victor M. Corman ; Mart M. Lamers ; Reina S. Sikkema ; Erwin De Bruin ; Felicity D. Chandler ; Yazdan Yazdanpanah ; Quentin Le Hingrat ; Diane Descamps ; Nadhira Houhou-Fidouh ; Chantal B E M. Reusken ; Berend-Jan Bosch ; Christian Drosten ; Marion P G. Koopmans ; Bart L. Haagmans | Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients. |
| 000243 (2020) |
Xiaodong Wu [République populaire de Chine] ; Bo Fu [République populaire de Chine] ; Lang Chen [République populaire de Chine] ; Yong Feng [République populaire de Chine] | Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China. |
| 000244 (2020) |
Junhua Deng [République populaire de Chine] ; Yipeng Jin [République populaire de Chine] ; Yuxiu Liu [République populaire de Chine] ; Jie Sun [République populaire de Chine] ; Liying Hao [République populaire de Chine] ; Jingjing Bai [République populaire de Chine] ; Tian Huang [République populaire de Chine] ; Degui Lin [République populaire de Chine] ; Yaping Jin [République populaire de Chine] ; Kegong Tian [République populaire de Chine] | Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals. |
| 000245 (2020) |
Anu Haveri [Finlande] ; Teemu Smura [Finlande] ; Suvi Kuivanen [Finlande] ; Pamela Österlund [Finlande] ; Jussi Hepojoki [Suisse] ; Niina Ikonen [Finlande] ; Marjaana Pitk Paasi [Finlande] ; Soile Blomqvist [Finlande] ; Esa Rönkkö [Finlande] ; Anu Kantele [Finlande] ; Tomas Strandin [Finlande] ; Hannimari Kallio-Kokko [Finlande] ; Laura Mannonen [Finlande] ; Maija Lappalainen [Finlande] ; Markku Broas [Finlande] ; Miao Jiang [Finlande] ; Lotta Siira [Finlande] ; Mika Salminen [Finlande] ; Taneli Puumalainen [Finlande] ; Jussi Sane [Finlande] ; Merit Melin [Finlande] ; Olli Vapalahti [Finlande] ; Carita Savolainen-Kopra [Finlande] | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. |
